KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Other Accumulated Expenses: 2013-2025

Historic Other Accumulated Expenses for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to $935,000.

  • Xenon Pharmaceuticals' Other Accumulated Expenses fell 13.43% to $935,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $935,000, marking a year-over-year decrease of 13.43%. This contributed to the annual value of $714,000 for FY2024, which is N/A change from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Other Accumulated Expenses stood at $935,000 for Q3 2025, which was up 112.98% from $439,000 recorded in Q2 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Other Accumulated Expenses peaked at $1.1 million during Q2 2024, and registered a low of $26,000 during Q3 2021.
  • For the 3-year period, Xenon Pharmaceuticals' Other Accumulated Expenses averaged around $578,400, with its median value being $582,000 (2024).
  • Data for Xenon Pharmaceuticals' Other Accumulated Expenses shows a peak YoY increase of 1,106.59% (in 2024) and a maximum YoY decrease of 86.13% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Xenon Pharmaceuticals' Other Accumulated Expenses stood at $118,000 in 2021, then soared by 188.98% to $341,000 in 2022, then soared by 137.78% to $107,000 in 2023, then surged by 909.35% to $714,000 in 2024, then fell by 13.43% to $935,000 in 2025.
  • Its last three reported values are $935,000 in Q3 2025, $439,000 for Q2 2025, and $450,000 during Q1 2025.